Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Glaukos (GKOS)

NYSE Health Care Health Care Equipment S&P MidCap 400S&P SmallCap 600
$224.41
+4.43 (+2.01%)
Close of Nov 06, 2026 · end-of-day data
Source: Glaukos's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$114.40M$159.25M$181.28M$236.98M$224.96M$294.01M$282.86M$314.71M$383.48M$507.44M
Cost of revenue$16.18M$21.05M$25.07M$38.59M$91.72M$66.63M$68.98M$75.58M$94.03M$111.81M
Gross profit$98.22M$138.20M$156.20M$198.40M$133.24M$227.38M$213.88M$239.14M$289.45M$282.76M
Research & development$29.22M$38.91M$49.68M$68.31M$85.39M$101.00M$123.27M$138.77M$136.43M$150.61M
Selling, general & admin$64.76M$96.26M$119.53M$176.63M$171.40M$179.26M$192.93M$224.07M$261.17M$331.75M
Operating income$4.24M-$2.28M-$13.00M-$50.29M-$123.55M-$32.87M-$82.31M-$128.70M-$122.37M-$199.60M
Interest expense———$2.56M$14.12M$13.37M$13.72M$13.63M$10.04M$4.63M
Pre-tax income$4.57M$1.00K-$12.37M-$50.04M-$132.31M-$49.27M-$98.43M-$133.73M-$145.60M-$193.04M
Income tax$43.00K$93.00K$583.00K-$65.46M-$11.97M$326.00K$766.00K$934.00K$771.00K-$5.35M
Net income$4.52M-$92.00K-$12.95M$15.42M-$120.35M-$49.59M-$99.19M-$134.66M-$146.37M-$187.69M
EBITDA$8.96M$3.20M-$6.74M-$43.99M-$94.17M-$3.21M-$50.74M-$95.05M-$86.72M-$161.51M
EPS (basic)$0.14$0.00$-0.37$0.41$-2.70$-1.07$-2.09$-2.78$-2.77$-3.28
EPS (diluted)$0.12$0.00$-0.37$0.37$-2.70$-1.07$-2.09$-2.78$-2.77$-3.28
Diluted shares36.46M34.38M35.32M41.15M44.50M46.42M47.44M48.43M52.76M57.19M
Gross margin85.9%86.8%86.2%83.7%59.2%77.3%75.6%76.0%75.5%55.7%
Operating margin3.7%-1.4%-7.2%-21.2%-54.9%-11.2%-29.1%-40.9%-31.9%-39.3%
Net margin4.0%-0.1%-7.1%6.5%-53.5%-16.9%-35.1%-42.8%-38.2%-37.0%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$6.49M$24.51M$29.82M$62.43M$96.60M$100.71M$119.53M$93.47M$169.63M$90.81M
Receivables$14.30M$16.66M$18.67M$38.42M$36.06M$33.44M$36.07M$39.85M$60.74M$108.61M
Inventory$6.84M$11.22M$13.28M$42.58M$15.81M$23.01M$37.84M$41.99M$57.68M$63.56M
Total current assets$120.02M$149.46M$176.57M$262.88M$469.44M$486.13M$443.86M$395.46M$449.79M$474.98M
Goodwill———$66.13M$66.13M$66.13M$66.13M$66.13M$66.13M$66.71M
Total assets$134.37M$165.84M$206.97M$818.40M$1.01B$1.05B$1.00B$940.41M$974.76M$893.49M
Total current liabilities$16.94M$26.79M$30.36M$57.70M$49.70M$63.36M$72.36M$74.01M$75.12M$101.28M
Total liabilities$17.10M$27.63M$33.11M$145.13M$338.05M$462.55M$472.38M$478.65M$207.82M$237.33M
Shareholders' equity$117.27M$138.20M$173.86M$673.27M$667.45M$587.15M$530.00M$461.77M$766.93M$656.15M

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$12.31M$26.09M$18.86M-$369.00K-$22.99M$24.71M-$33.08M-$57.76M-$61.32M-$14.79M
Capital expenditures$6.28M$6.31M$10.31M$4.72M$6.93M$47.78M$30.27M$20.25M$6.30M$7.67M
Free cash flow$6.03M$19.78M$8.55M-$5.09M-$29.92M-$23.08M-$63.35M-$78.01M-$67.62M-$22.45M
Investing cash flow-$26.12M-$12.39M-$26.40M$43.43M-$205.06M-$58.23M$44.78M$14.10M$47.83M-$77.61M
Financing cash flow-$1.64M$4.67M$21.58M-$9.64M$262.54M$39.26M$6.25M$15.04M$91.54M$11.89M
Stock-based compensation$8.79M$17.59M$25.70M$36.39M$46.48M$30.15M$38.56M$43.53M$50.21M$63.22M
Depreciation & amortization$4.72M$5.48M$6.26M$6.31M$29.38M$29.66M$31.58M$33.65M$35.65M$38.09M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.